期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Chinese Orthopedic Surgeons' Practice Regarding Postoperative Thromboembolic Prophylaxis after Major Orthopedic Surgery
1
作者 Zhi-jian Sun Gui-xing Qiu +2 位作者 Xi-sheng Weng Yu Zhao Jin Jin 《Chinese Medical Sciences Journal》 CAS CSCD 2012年第3期141-146,共6页
Objective To assess Chinese surgeon practice of thromboprophylaxis following major orthopedic surgery. Methods A questionnaire survey was conducted amongst Chinese orthopedic surgeons. A total of 293 surgeons were sur... Objective To assess Chinese surgeon practice of thromboprophylaxis following major orthopedic surgery. Methods A questionnaire survey was conducted amongst Chinese orthopedic surgeons. A total of 293 surgeons were surveyed concerning five key aspects of thromboembolic prophylaxis after major orthopedic surgery at the proseminar of Chinese guidelines for prevention of venous thromboembolism (VTE) after major orthopedic surgery in January of 2009. Results Totally, 208 surgeons (71.0%) responded, successfully completing the questionnaire. Of them, 57.6% respondents selected combined basic, mechanical, and pharmacologic methods for thromboprophylaxis; 51.0% respondents prefer starting prophylaxis 12-24 hours after surgery; 60.3% surgeons would use chemoprophylaxis for 7-10 days; 47.6% respondents prefer VTE prevention based on patients' special conditions and needs upon discharge. "Safety" was the most repeated and emphasized factor during VTE prophylaxis. Conclusions Multimodal thromboprophylaxis is frequently used after major orthopedic surgery. Half surgeons prefer to start chemoprophylaxis 12-24 hours after surgery. Thromboprophylaxis regimen varies for discharged patients. 展开更多
关键词 venous thromboembolism major orthopedic surgery survey THROMBOPROPHYLAXIS
下载PDF
HINT1基因变异致常染色体隐性遗传轴索型神经病伴神经性肌强直藏族家系及文献复习
2
作者 茹喜芳 赵蓉 +6 位作者 范燕彬 王爽 叶一林 徐贝宇 李淳德 黄真 熊晖 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2024年第2期128-133,共6页
目的分析HINT1基因变异致常染色体隐性遗传轴索型神经病伴神经性肌强直(ARAN-NM)的特点。方法回顾性病例总结。分析2023年8月在北京大学第一医院儿科确诊为ARAN-NM的2例藏族兄妹的临床资料。检索各个数据库收录的相关中国病例的文献并... 目的分析HINT1基因变异致常染色体隐性遗传轴索型神经病伴神经性肌强直(ARAN-NM)的特点。方法回顾性病例总结。分析2023年8月在北京大学第一医院儿科确诊为ARAN-NM的2例藏族兄妹的临床资料。检索各个数据库收录的相关中国病例的文献并进行分析。结果先证者及其兄分别为13岁和19岁,均于11岁出现步态异常,其后出现足内翻及跛行、拇指力弱,先证者合并神经性肌强直。查体先证者及其兄均四肢肌力下降,拇指和下肢远端为著,先证者下肢远端肌肉萎缩,先证者兄双手肌肉萎缩,二人双足均马蹄内翻畸形。先证者肌电图(EMG)检查示周围神经病损(运动和感觉纤维轴索受累,远端受累为重)和肌强直电位。家系全外显子组测序检测到二人HINT1基因纯合致病性变异[c.169A>G(p.K57E)],确诊ARAN-NM。先证者口服卡马西平后神经性肌强直症状缓解,麻木、无力症状明显改善。先证者和其兄行骨科手术治疗和康复治疗后足部畸形及步态明显改善。检索到符合条件的中文文献2篇(2例),英文文献4篇(8例)。加上本例先证者及其兄共12例,10例有临床资料,起病年龄为2~16岁(1例未知),诊断年龄为13~33岁,9例有肌无力,肌无力以远端为著,8例伴神经性肌强直,9例出现肌肉萎缩,7例合并足畸形,2例合并感觉障碍,9例检测肌酸激酶的患者均有升高,EMG均提示神经源性损伤,6例可见神经性肌强直放电,3例接受卡马西平治疗,部分症状缓解。12例均有遗传学资料,均为错义突变/无义突变,高频变异为c.112T>C(p.C38R)。结论ARAN-NM是由HINT1基因变异引起的常染色体隐性遗传性罕见神经肌肉病,临床表现无民族差异,主要为肢体远端无力伴神经性肌强直,卡马西平可缓解部分症状,骨科矫形治疗可改善足部畸形和步态。 展开更多
关键词 腓骨肌萎缩症 遗传性周围神经病 常染色体隐性遗传轴索型神经病伴神经性肌强直 HINT1基因 卡马西平 骨科矫形外科手术
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部